Biodelivery Sciences International Profit Margin

As of the most recent data (December 2021), BDSI shows a profit margin of 50.9%. That compares with 16.43% in the prior-year period — up 209.8% year over year. That is above the Healthcare sector average of 15.29%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BDSI's profit margin is now 50.9% (was 16.43%) — a 209.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biodelivery Sciences International is outperforming or lagging.

The Healthcare sector average profit margin is about 15.29%. Biodelivery Sciences International is at 50.9%, which is higher that average. That is roughly 232.9% above the sector mean. Use the comparison chart on this page to see how BDSI stacks up against individual peers as well.

That compares with 16.43% in the prior-year period — up 209.8% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Biodelivery Sciences International with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Biodelivery Sciences International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 50.9%) with ownership activity and broader fundamentals.